21468241

Source:http://linkedlifedata.com/resource/pubmed/id/21468241

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018787, umls-concept:C0030705, umls-concept:C0035647, umls-concept:C0087111, umls-concept:C0205164, umls-concept:C0205210, umls-concept:C0301630, umls-concept:C0332120, umls-concept:C0441471, umls-concept:C0442027, umls-concept:C0948089, umls-concept:C1999375
pubmed:dateCreated	2011-4-6
pubmed:abstractText	Ticagrelor, the first direct-acting, reversibly binding oral P2Y12 receptor antagonist, appears to have a favorable efficacy and safety profile.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-10517731, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-10761167, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-11031222, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-11054084, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-12750303, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-1510701, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-15269827, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-16476694, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-16606819, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17056321, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17127485, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17169448, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17679616, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17980250, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17980251, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-17982182, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-19332184, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-19717846, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-19923168, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-19946242, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20024505, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20079528, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20124464, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20539844, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20620737, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20801498, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-20832963, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-21079055, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-2394000, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-2962787, http://linkedlifedata.com/resource/pubmed/commentcorrection/21468241-7497483
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101256593
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1555-175X
pubmed:author	pubmed-author:DíezJosé GJG, pubmed-author:LomboBernardoB
pubmed:issnType	Electronic
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	31-42
pubmed:dateRevised	2011-7-28
pubmed:year	2011
pubmed:articleTitle	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.
pubmed:affiliation	Department of Medicine, Yale School of Medicine, New Haven, CT, USA;
pubmed:publicationType	Journal Article